Intuitive Surgical, Inc. ISRG
Price alert —
Sign in to get a one-time email the moment ISRG crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · ISRG
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $nanB | $nanB | $nanB | — | nan% | nan% |
| 2026-03-31 | $2.8B | $0.8B | $0.9B | $0.8B | 29.6% | 30.9% |
| 2025-12-31 | $2.9B | $0.8B | $0.9B | $0.7B | 27.7% | 30.2% |
| 2025-09-30 | $2.5B | $0.7B | $0.8B | $0.7B | 28.1% | 30.3% |
| 2025-06-30 | $2.4B | $0.7B | $0.7B | $0.6B | 27.0% | 30.5% |
| 2025-03-31 | $2.3B | $0.7B | $0.6B | $0.5B | 31.0% | 25.7% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare ISRG vs peers
Line ISRG up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with ISRG
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 20 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-07-16 | 2.80 | 2.50 | +11.9% | -14.2% |
| 2026-04-21 | 2.50 | 2.11 | +18.7% | +7.2% |
| 2026-01-22 | 2.53 | 2.27 | +11.6% | -0.3% |
| 2025-10-21 | 2.40 | 1.99 | +20.7% | +13.9% |
| 2025-07-22 | 2.19 | 1.92 | +14.1% | -1.8% |
| 2025-04-22 | 1.81 | 1.73 | +4.4% | +1.9% |
| 2025-01-23 | 2.21 | 1.79 | +23.7% | -4.0% |
| 2024-10-17 | 1.84 | 1.64 | +12.2% | +10.0% |
| 2024-07-18 | 1.78 | 1.54 | +15.5% | +9.3% |
| 2024-04-18 | 1.50 | 1.42 | +6.0% | -1.7% |
| 2024-01-23 | 1.60 | 1.49 | +7.7% | -0.4% |
| 2023-10-19 | 1.46 | 1.42 | +3.2% | -2.4% |
| 2023-07-20 | 1.42 | 1.33 | +6.9% | -3.2% |
| 2023-04-18 | 1.23 | 1.20 | +2.8% | +10.9% |
| 2023-01-24 | 1.23 | 1.25 | -1.9% | -5.5% |
| 2022-10-18 | 1.19 | 1.12 | +6.4% | +9.0% |
| 2022-07-21 | 1.14 | 1.20 | -4.8% | -5.7% |
| 2022-04-21 | 1.13 | 1.08 | +5.1% | -14.3% |
| 2022-01-20 | 1.30 | 1.28 | +1.6% | -7.9% |
| 2021-10-19 | 1.19 | 1.16 | +2.7% | +1.0% |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| ISRG ★ | $122B | 39.7 | 28.8 | 11.1 | 27.3 | 7.0 | 66.8% | 18.5% | 26.5% | — |
| LLY | $1,051B | 41.8 | 26.3 | 14.6 | 30.1 | 33.8 | 82.8% | 55.5% | 169.9% | 0.87% |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 17.7 | 4.0 | 19.5% | 0.4% | 61.5% | 5.88% |
| JNJ | $609B | 29.3 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 36.0 | 13.2 | 4.8 | 12.1 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | $143B | 19.1 | 8.8 | 2.3 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.67% |
| TMO | $198B | 29.2 | 19.5 | 4.4 | 21.1 | 3.8 | 40.9% | 6.2% | 11.3% | 2.79% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 36.14%
| Holder | Shares | % out |
|---|---|---|
| Blackrock Inc. | 30,075,905 | 8.49% |
| Vanguard Capital Management LLC | 23,079,490 | 6.52% |
| State Street Corporation | 15,846,973 | 4.47% |
| Price (T.Rowe) Associates Inc | 12,520,007 | 3.54% |
| Invesco Ltd. | 11,190,485 | 3.16% |
| Geode Capital Management, LLC | 8,466,851 | 2.39% |
| Capital World Investors | 8,048,010 | 2.27% |
| Vanguard Portfolio Management LLC | 7,233,971 | 2.04% |
| Morgan Stanley | 6,058,840 | 1.71% |
| FMR, LLC | 5,477,234 | 1.55% |
Insider activity · 90d
0 buys / 7 sells · ratio 0.0 · Finnhub
- Rosa David J. M 5,730
- Rosa David J. F 246,856 @ $411.55
- Rosa David J. M 247,803
- Brosius Mark SELL 1,406 @ $414.13
- Brosius Mark SELL 1,431 @ $412.16
- Brosius Mark SELL 1,454 @ $424.14
- LOEB GARY SELL 5,720 @ $424.14
- Rosa David J. M 1,358
- Rosa David J. F 245,893 @ $426.61
- Rosa David J. M 246,567
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 8-K | 2026-07-16 | 8-K | view · |
| 4 | 2026-07-13 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-12 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-10 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-10 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-10 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-02 | PRIMARY DOCUMENT | view · |
| 8-K | 2026-05-28 | 8-K | view · |
| 4 | 2026-05-22 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-20 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-11 | PRIMARY DOCUMENT | view · |
| 8-K | 2026-05-04 | 8-K | view · |
| 4 | 2026-05-01 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-30 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-30 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-30 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-30 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-30 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-30 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-30 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-30 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-30 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-29 | PRIMARY DOCUMENT | view · |
| 10-Q | 2026-04-22 | 10-Q | view · |
| 8-K | 2026-04-21 | 8-K | view · |
| DEF 14A | 2026-03-13 | DEF 14A | view · |
| 4 | 2026-03-11 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-10 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-05 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-03 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-03 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-03 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-03 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-02 | PRIMARY DOCUMENT | view · |
| 8-K | 2026-03-02 | 8-K | view · |
| 4 | 2026-03-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-27 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-27 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-27 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-27 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-27 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-27 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-27 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-27 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-27 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-27 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-11 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-11 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-10 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-10 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-10 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-10 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-10 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-10 | PRIMARY DOCUMENT | view · |
| 4 | 2026-02-10 | PRIMARY DOCUMENT | view · |
| 10-K | 2026-02-03 | 10-K | view · |
About ISRG
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 a…
Options picks · ISRG
ITM + OTM ideas from the latest scanLoading…
Congress trades · ISRG
STOCK Act disclosuresLoading…
SEC filings & insiders · ISRG
EDGAR · liveLoading…
Holders · ISRG
Institutions & insider activityLoading…